Abbott Hit With 5 AndroGel Suits In FDA Probe's Wake
Abbott Laboratories Inc. and AbbVie Inc. downplayed the stroke and heart attack risks associated with testosterone replacement treatment AndroGel, according to five lawsuits filed in Illinois federal court Tuesday, just days...To view the full article, register now.
Already a subscriber? Click here to view full article